Showing results (1-10 of 681) with videos related to
Sort By:
Pageof 69
Current Hematologic Malignancy Reports|May 26, 2018
Management of Myelofibrosis-Related CytopeniasPrithviraj Bose, Srdan VerstovsekInternational Journal of Hematology|October 21, 2019
Mutational profiling in myelofibrosis: implications for managementPrithviraj Bose, Srdan VerstovsekExpert Opinion on Investigational Drugs|November 2, 2016
Investigational histone deacetylase inhibitors (HDACi) in myeloproliferative neoplasmsPrithviraj Bose, Srdan VerstovsekExpert Opinion on Pharmacotherapy|November 8, 2016
Myelofibrosis: an update on drug therapy in 2016Prithviraj Bose, Srdan VerstovsekTherapeutic Advances in Hematology|September 14, 2019
Updates in the management of polycythemia vera and essential thrombocythemiaPrithviraj Bose, Srdan VerstovsekClinical Lymphoma, Myeloma & Leukemia|August 2, 2017
Developmental Therapeutics in Myeloproliferative NeoplasmsPrithviraj Bose, Srdan VerstovsekBlood|May 14, 2017
JAK2 inhibitors for myeloproliferative neoplasms: what is next?Prithviraj Bose, Srdan VerstovsekJournal of the National Comprehensive Cancer Network : JNCCN|December 14, 2016
Drug Development Pipeline for Myeloproliferative Neoplasms: Potential Future Impact on Guidelines and ManagementPrithviraj Bose, Srdan VerstovsekClinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Prognosis of Primary Myelofibrosis in the Genomic EraPrithviraj Bose, Srdan VerstovsekCancer|December 31, 2015
The evolution and clinical relevance of prognostic classification systems in myelofibrosisPrithviraj Bose, Srdan VerstovsekPageof 69